Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas

Discovery Medicine

Volumn 17, Issue 92, 2014, Pages 67-73

  Guo, Mingzhou ^a,b   Jia, Yan ^a,c   Yu, Zhengtao ^c   House, Michael G ^b   Esteller, Manel ^b   Brock, Malcolm V ^b   Herman, James G ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BISULFITE; BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P73; RETINOID RELATED ORPHAN RECEPTOR BETA; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; ENDOCRINE TUMOR; EPIGENETICS; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ISLET CELL CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

DNA METHYLATION; EPIGENESIS, GENETIC; GENES, TUMOR SUPPRESSOR; HUMANS; ISLETS OF LANGERHANS; PANCREAS, EXOCRINE; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 84894481117     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, Brennan M, Cameron JL, Klimstra DS. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 160:953-962, 2002.
2. Audrey V, Joseph H, Rich S, Ralph HH, Michael G. Pancreatic cancer. Lancet 378: 607-620, 2011.
3. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168-174, 2000.
4. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 95:11891-11896, 1998.
5. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27-32, 1994.
6. Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA. Inherited predisposition to pancreatic cancer. Gut 48:143-147, 2001.
7. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67-70, 1999.
8. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229, 2001.
9. Goggins M, Kern SE, Offerhaus JA, Hruban RH. Progress in cancer genetics: lessons from pancreatic cancer. Ann Oncol 10(Suppl 4):4-8, 1999.
10. Herman JG, GraffJR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821-9826, 1996.
11. House MG, Guo M, Iacobuzio-Donahue C, Herman JG. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 24:193-198, 2003.
12. Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 6:2969-2972, 2000.
13. Irmgard H, Andreas W, Gaelle E, Maria S, Dario S, Vincent R, Tobias S, Albert L, Saskia MB, Mohamed B, Thomas MR, William RS, Francesco H, Sauveur-Michel M. K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivo. PloS One 7(8):1-14, 2012.
14. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428, 2002.
15. Klein WM, Hruban RH, Klein-Szanto AJ, Wilentz RE. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod Pathol 15:441-447, 2002.
16. Luttges J, Galehdari H, Brocker V, Schwarte-WaldhoffI, Henne-Bruns D, Kloppel G, Schmiegel W, Hahn SA. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158:1677-1683, 2001.
17. Michl P, Gress TM. Current concepts and novel targets in advanced pancreatic cancer. Gut 62(2):317-326, 2013.
18. Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 84:253-262, 2001a.
19. Moore PS, Missiaglia E, Antonello D, Zamo A, Zamboni G, Corleto V, Falconi M, Scarpa A. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes Chromosomes Cancer 32:177-181, 2001b.
20. Moore PS, Beghelli S, Zamboni G, Scarpa A. Genetic abnormalities in pancreatic cancer. Mol Cancer 2:7, 2003.
21. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556-1560, 1994.
22. Rebecca S, Deepa N, Ahmedin J. Cancer Statistics, 2012. CA Cancer J Clin 62:10-29, 2012.
23. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57:1731-1734, 1997.
24. Schutte M, Rozenblum E, Moskaluk CA, Guan X, Hoque AT, Hahn SA, da Costa LT, de Jong PJ, Kern SE. An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res 55:4570-4574, 1995.
25. Thompson D, Easton DF. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358-1365, 2002.
26. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60:1835-1839, 2000.
27. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 9:138-141, 1993.
28. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988.
29. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 61:827-830, 2001.
30. Yamamoto H, Itoh F, Nakamura H, Fukushima H, Sasaki S, Perucho M, Imai K. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 61:3139-3144, 2001.